EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 30 / No 4 (Avril 2014) Med Sci (Paris), 30 4 (2014) 378-384 References
Free Access
Issue
Med Sci (Paris)
Volume 30, Number 4, Avril 2014
Page(s) 378 - 384
Section Microenvironnements tumoraux : conflictuels et complémentaires
DOI https://doi.org/10.1051/medsci/20143004010
Published online 05 May 2014
  1. Bidard FC, Poupon MF. Biologie du processus métastatique. Med Sci (Paris) 2012 ; 28 : 89–95. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977 ; 197 : 893–895. [CrossRef] [PubMed] [Google Scholar]
  3. Engel J, Eckel R, Kerr J, et al. The process of metastasisation for breast cancer. Eur J Cancer 2003 ; 39 : 1794–1806. [CrossRef] [PubMed] [Google Scholar]
  4. Schmidt-Kittler O, Ragg T, Daskalakis A, et al. From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci USA 2003 ; 100 : 7737–7742. [CrossRef] [Google Scholar]
  5. Sola M, Margeli M, Castella E, et al. Prognostic value of hematogenous dissemination and biological profile of the tumor in early breast cancer patients: a prospective observational study. BMC Cancer 2011 ; 11 : 252. [CrossRef] [PubMed] [Google Scholar]
  6. Husemann Y, Geigl JB, Schubert F, et al. Systemic spread is an early step in breast cancer. Cancer Cell 2008 ; 13 : 58–68. [CrossRef] [PubMed] [Google Scholar]
  7. Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer 2009 ; 9 : 302–312. [CrossRef] [PubMed] [Google Scholar]
  8. Damsky WE, Theodosakis N, Bosenberg M. Melanoma metastasis: new concepts and evolving paradigms. Oncogene 2013 ; 3 juin (online). doi : 10.1038/onc.2013.194. [Google Scholar]
  9. Kivela T, Eskelin S, Kujala E. Metastatic uveal melanoma. Int Ophthalmol Clin 2006 ; 46 : 133–149. [CrossRef] [PubMed] [Google Scholar]
  10. Chaturvedi A, Hoffman LM, Welm AL, et al. The EWS/FLI Oncogene drives changes in cellular morphology, adhesion, and migration in Ewing sarcoma. Genes Cancer 2012 ; 3 : 102–116. [CrossRef] [PubMed] [Google Scholar]
  11. Vinokurova S, Wentzensen N, Einenkel J, et al. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract. J Natl Cancer Inst 2005 ; 97 : 1816–1821. [CrossRef] [PubMed] [Google Scholar]
  12. Stoecklein NH, Hosch SB, Bezler M, et al. Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. Cancer Cell 2008 ; 13 : 441–453. [CrossRef] [PubMed] [Google Scholar]
  13. Eyles J, Puaux AL, Wang X, et al. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J Clin Invest 2010 ; 120 : 2030–2039. [CrossRef] [PubMed] [Google Scholar]
  14. Rhim AD, Mirek ET, Aiello NM, et al. EMT and dissemination precede pancreatic tumor formation. Cell 2012 ; 148 : 349–361. [CrossRef] [PubMed] [Google Scholar]
  15. Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature 2005 ; 436 : 518–524. [CrossRef] [PubMed] [Google Scholar]
  16. Bernards R, Weinberg RA. A progression puzzle. Nature 2002 ; 418 : 823. [CrossRef] [PubMed] [Google Scholar]
  17. Thiery JP, Chua K, Sim WJ, Huang R. La transition épithéliomésenchymateuse au cours du développement dans la fibrose et dans la progression tumorale. Bull Cancer 2010 ; 97 : 1285–1295. [PubMed] [Google Scholar]
  18. De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 2013 ; 13 : 97–110. [CrossRef] [PubMed] [Google Scholar]
  19. Sasaki K, Natsugoe S, Ishigami S, et al. Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma. J Exp Clin Cancer Res 2009 ; 28 : 158. [CrossRef] [PubMed] [Google Scholar]
  20. Wushou A, Pan HY, Liu W, et al. Correlation of increased twist with lymph node metastasis in patients with oral squamous cell carcinoma. J Oral Maxillofac Surg 2012 ; 70 : 1473–1479. [CrossRef] [PubMed] [Google Scholar]
  21. Bidard FC, Pierga JY, Vincent-Salomon A, Poupon MF. A class action against the microenvironment: do cancer cells cooperate in metastasis?. Cancer Metastasis Rev 2008 ; 27 : 5–10. [CrossRef] [PubMed] [Google Scholar]
  22. Paez-Ribes M, Allen E, Hudock J, et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009 ; 15 : 220–231. [Google Scholar]
  23. Chouaib S, Messai Y, Couve S, et al. Hypoxia promotes tumor growth in linking angiogenesis to immune escape. Front Immunol 2012 ; 3 : 21. [CrossRef] [PubMed] [Google Scholar]
  24. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009 ; 9 : 239–252. [CrossRef] [PubMed] [Google Scholar]
  25. Toh B, Wang X, Keeble J, et al. Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol 2011 ; 9 : e1001162. [CrossRef] [PubMed] [Google Scholar]
  26. Tomita T, Sakurai Y, Ishibashi S, Maru Y. Imbalance of Clara cell-mediated homeostatic inflammation is involved in lung metastasis. Oncogene 2011 ; 30 : 3429–3439. [CrossRef] [PubMed] [Google Scholar]
  27. Zhang QW, Liu L, Gong CY, et al. Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS One 2012 ; 7 : e50946. [Google Scholar]
  28. Hirshberg A, Leibovich P, Horowitz I, Buchner A. Metastatic tumors to postextraction sites. J Oral Maxillofac Surg 1993 ; 51 : 1334–1337. [CrossRef] [PubMed] [Google Scholar]
  29. Hiratsuka S, Ishibashi S, Tomita T, et al. Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci. Nat Commun 2013 ; 4 : 1853. [CrossRef] [PubMed] [Google Scholar]
  30. Demicheli R, Retsky MW, Hrushesky WJ, et al. The effects of surgery on tumor growth: a century of investigations. Ann Oncol 2008 ; 19 : 1821–1828. [CrossRef] [PubMed] [Google Scholar]
  31. Strauss DC, Thomas JM. Transmission of donor melanoma by organ transplantation. Lancet Oncol 2010 ; 11 : 790–796. [CrossRef] [PubMed] [Google Scholar]
  32. Kiessling R, Wasserman K, Horiguchi S, et al. Tumor-induced immune dysfunction. Cancer Immunol Immunother 1999 ; 48 : 353–362. [CrossRef] [PubMed] [Google Scholar]
  33. Tatsumi T, Kierstead LS, Ranieri E, et al. Disease-associated bias in T helper type 1 (Th1)/Th2 CD4+ T cell responses against MAGE-6 in HLA-DRB10401+ patients with renal cell carcinoma or melanoma. J Exp Med 2002 ; 196 : 619–628. [CrossRef] [PubMed] [Google Scholar]
  34. Kusmartsev S, Su Z, Heiser A, et al. Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma. Clin Cancer Res 2008 ; 14 : 8270–8278. [CrossRef] [PubMed] [Google Scholar]
  35. Luzzi KJ, MacDonald IC, Schmidt EE, et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 1998 ; 153 : 865–873. [CrossRef] [PubMed] [Google Scholar]
  36. Tsai JH, Donaher JL, Murphy DA, et al. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 2012 ; 22 : 725–736. [CrossRef] [PubMed] [Google Scholar]
  37. Malanchi I, Santamaria-Martinez A, Susanto E, et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 2012 ; 481 : 85–89. [CrossRef] [Google Scholar]
  38. Oskarsson T, Massague J. Extracellular matrix players in metastatic niches. EMBO J 2012 ; 31 : 254–256. [CrossRef] [PubMed] [Google Scholar]
  39. Quesnel B. « Je te tiens, tu me tiens »… Dormance tumorale : un équilibre instable ? Med Sci (Paris) 2008 ; 24 : 575–576. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  40. Narang V, Wong SY, Leong SR, et al. Selection of mesenchymal-like metastatic cells in primary tumors: an in silico investigation. Front Immunol 2012 ; 3 : 88. [CrossRef] [PubMed] [Google Scholar]
  41. Ansieau S, Caron de Fromentel C, Bastid J, et al. Rôle de la transition épithéliomésenchymateuse dans la progression tumorale. Bull Cancer 2010 ; 97 : 7–15. [PubMed] [Google Scholar]
  42. Bidard FC, Pierga JY, Soria JC, Thiery JP. Translating metastasis-related biomarkers to the clinic-progress and pitfalls. Nat Rev Clin Oncol 2013 ; 10 : 169–179. [CrossRef] [PubMed] [Google Scholar]
  43. Fridman WH, Sautès-Fridman C. Le microenvironnement tumoral : matrice nourricière, champ de bataille et cible thérapeutique des cancers. Med Sci (Paris) 2014 ; 30 : 359–365. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  44. Provot S. Contrôle de la croissance et de la dissémination tumorales par le microenvironnement : certitudes et hypothèses émergentes. Med Sci (Paris) 2014 ; 30 : 366–371. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  45. Puisieux A, Ansieau S. La dissémination précoce de cellules métastatiques. Med Sci (Paris) 2009 ; 25 : 28–30. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  46. Hasmim M, Messai Y, Zaeem Noman M, Chouaib S. L’hypoxie tumorale : un déterminant clé de la réactivité stromale et de la réponse antitumorale. Med Sci (Paris) 2014 ; 30 : 422–428. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  47. Bruchard M, Ghiringhelli F. Microenvironnement tumoral : cellules régulatrices et cytokines immunosuppressives. Med Sci (Paris) 2014 ; 30 : 429–435. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  48. Azzi A, Gavard J. Vaisseaux sanguins et tumeurs ou l’art du dialogue. Med Sci (Paris) 2014 ; 30 : 408–414. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  49. Galon J, Bindea G, Mlecnik B, et al. Micro-environnement immunitaire et cancer : intérêt de l’immunoscore pour prédire l’évolution clinique. Med Sci (Paris) 2014 ; 30 : 439–444. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.